The Biden Administration's historic investment in pandemic preparedness and biodefense in the FY 2023 President's Budget
The White House, March 28, 2022
Abstract
The Biden administration requested an $88.2 billion investment in pandemic preparedness and biodefense, to be distributed across several entities, including HHS, CDC, NIH, FDA, USAID, and the Department of State. This historic investment aims to improve capabilities in preventing, detecting, and responding to future biological threats. A significant portion of the budget, $40 billion, is allocated to advanced development and manufacturing of countermeasures, while other funds are earmarked for strengthening public health infrastructure, early warning systems via CDC, supporting basic research through NIH, modernizing regulatory infrastructure via FDA, advancing biosafety and biosecurity, and enhancing the global response to biological threats via USAID and the World Bank. Collectively, these investments aim to build resilience against future pandemics and strengthen international systems for early detection and response. – AI-generated abstract.
